LOG IN
About Us
Advertise
Edit Your Profile
Contact Us
General News
Industry Press Releases
Supplier Press Releases
FDA Press Releases (RSS)
CDRH News (RSS)
Submit a Press Release
Devine Guidance
Summit Nuts ‘n’ Bolts
Summit Soapbox
Career Path by Coach Kris
MEDdesign
Ask the Engineer
From the Editor’s Desk
Biros’ Blog
Products
Services
Companies A-Z
Associations
Publications
Government Agencies
Academic Links
Supplier Press Releases
White Papers
Video
Podcasts
News
Events
Features
SurModics to Webcast Annual Meeting on February 6
2/3/2012 11:26:00 PM
EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--SurModics announced today that it will host a live webcast of its Annual Meeting of Shareholders on Monday, February 6, at 4:00 p.m. CT.
PerkinElmer Highlights New Drug Discovery Research Solutions at the Society for Laboratory Automation and Screening (SLAS) 2012 Conference
2/3/2012 10:30:00 PM
SAN DIEGO--(BUSINESS WIRE)--PerkinElmer will be showcasing several new drug discovery technologies and applications – ALPHA technology and LANCE® Ultra technologies for epigenetics research
Research and Markets: GIA - Mammography Equipment - Global Strategic Business Report
2/3/2012 5:25:00 PM
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/a83af9/mammography_equipm) has announced the addition of the "Mammography Equipment - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for Mammography Equipment in Units and US$ Millions by the following Product Segments: Analog Mammography Equipment, and Digital Mammography Equipment. The US market is separately analyzed by - Analog Mammography Equipmen
VuCOMP Receives Premarket Approval for Mammography Computer-Aided Detection System
2/3/2012 4:20:00 PM
PLANO, Texas--(BUSINESS WIRE)--VuCOMP, Inc. is pleased to announce premarket approval (PMA) of M-Vu®, a cutting--edge CAD system for film mammography. This is the first new mammography CAD system approved by the FDA since 2007.
Research and Markets: International Directory of Medical Devices & Diagnostics Companies 2012: A Must for MD&D Contacts Worldwide
2/3/2012 3:07:00 PM
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/31fb9a/international_dire) has announced the addition of the "International Directory of Medical Devices & Diagnostics Companies 2012" directory to their offering. Profiling more than 6,000 companies worldwide the International Directory of Medical Devices & Diagnostics Companies is the most comprehensive and accurate Directory of companies and executives in the MD&D industry that have ever been
Research and Markets: Medical Oxygen Systems 2011 - Global Strategic Business Report
2/3/2012 3:01:00 PM
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/a2054f/medical_oxygen_sys) has announced the addition of the "Medical Oxygen Systems - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for Medical Oxygen Systems in US$ Million by the following Product Segments: Oxygen Concentrators, Liquid Oxygen Systems, Oxygen Cylinders & Regulators, and Oxygen Conserving Devices. The report provides separate com
Corgenix to Host Conference Call to Discuss Second Quarter Results
2/3/2012 2:15:00 PM
DENVER--(BUSINESS WIRE)--Corgenix Medical Corporation (OTC BB: CONX) will host a conference call on Feb. 14, 2012 at 4 p.m. EST to discuss Q4 2011 financial performance as well as product development and marketing activities
VeriTeQ Acquisition Corporation to Offer Implantable RFID Microchip for Traceability of Breast Implants and Other Medical Devices
2/3/2012 1:30:00 PM
DELRAY BEACH, Fla.--(BUSINESS WIRE)--VeriTeQ offers its FDA-cleared microchip to identify breast implants and medical devices to ensure traceability. Company has contract with medical device company to identify vascular ports.
Health Discovery Corporation广受欢迎的黑色素瘤风险分析手机应用程序MelApp推出Android版
2/3/2012 1:21:00 PM
乔治亚州萨凡纳--(BUSINESS WIRE)--(美国商业资讯)--Health Discovery Corporation (OTCBB: HDVY)今天面向Android™设备推出了其广受欢迎的MelApp移动应用程序。Health Discovery Corporation是一家分子诊断公司,推出了首个基于SVM的图像分析iPhone应用程序—MelApp,用于评估黑色素瘤风险。现在,注重健康的消费者可以轻松了解黑色素瘤知识,并能通过他们的iPhone、iPod Touch和iPad以及Android智能手机随时随地识别他们皮肤上可能需要专家诊断的部位。 MelApp最早在今夏推出iPhone版,它使用受专利保护的高度精密的数学算法与基于图像的模式识别技术对上载的图像进行分析。该应用程序的验证采用了约翰霍普金斯大学医学中心(Johns Hopkins University Medical Center)授权的一个图像数据库,并使用设备的摄像头功能,在数秒内对用户拍摄的皮肤病灶进行风险分析。另外,MelApp还可利用智能手机的GPS功能将用户转至专攻黑色素瘤领域的医生进行适当的
Advanced ICU Care Begins Delivering 24/7 Coverage and a Tele-ICU Solution to Critically Ill Patients at St. Mary’s Hospital
2/3/2012 1:00:00 PM
CENTRALIA, Ill.--(BUSINESS WIRE)--St. Mary’s Hospital today announced the successful implementation of the most advanced critical care telemedicine program available in hospital intensive care units. On January 23, St. Mary’s partnered with Advanced ICU Care, the nation’s largest independent provider of tele-ICU services, to deliver monitoring by highly trained intensivist physicians and critical care specialists 24 hours a day, seven days a week, providing an extra layer of care that enhances p
Teleflex to Focus on Innovative Products at the Society of Critical Care Medicine’s 41st Critical Care Congress
2/3/2012 12:00:00 PM
LIMERICK, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE: TFX) will showcase a number of anesthesia, respiratory therapy and vascular access products at the Society of Critical Care Medicine’s 41st Critical Care Congress February 4-8, in Houston, Texas. Teleflex will highlight: The Teleflex ISIS® HVT™, the first convertible endotracheal tube, features an integrated suction port and separate suction line allowing for subglottic secretion suctioning on demand. Now clinicians can be free from th
Results from Solitaire with the Intention for Thrombectomy (SWIFT) Study Announced at the International Stroke Conference on February 3
2/3/2012 11:35:00 AM
--(BUSINESS WIRE)--Covidien: WHO: Jeffrey Saver, MD SWIFT, Lead Author Professor of Neurology and Director UCLA Stroke Center, David Geffen School of Medicine University of California, Los Angeles WHAT: Results from the Solitaire with the Intention for Thrombectomy (SWIFT) Study will be announced at a press conference at 8AM CT – followed by a late breaking trial presentation at 12 PM CT. The Solitaire™ FR Revascularization Device is a stent-based mechanical thrombectomy system from
Sirona Reports Fiscal 2012 First Quarter Results
2/3/2012 11:30:00 AM
LONG ISLAND CITY, N.Y.--(BUSINESS WIRE)--Sirona (Nasdaq: SIRO), the dental technology leader, today announced its financial results for the quarter ended December 31, 2011. First Quarter Fiscal 2012 vs. First Quarter Fiscal 2011 Financial Results Revenue was $258.1 million, an increase of $22.5 million or up 9.5% (up 10.2% on a constant currency basis), with growth rates for the Company's business segments as follows: Imaging Systems increased 23.8% (up 24.3% constant currency); Instruments incr
ヘルス・ディスカバリー・コーポレーション、メラノーマリスクを評価する高人気の携帯電話用アプリMelAppのAndroidバージョンをリリース
2/3/2012 10:39:00 AM
米ジョージア州サバンナ--(BUSINESS WIRE)--(ビジネスワイヤ)-- 分子診断法企業のヘルス・ディスカバリー・コーポレーション(OTCBB: HDVY)は本日、当社の高人気モバイルアプリ「MelApp」のAndroid™(アンドロイド)バージョンをリリースしました。MelAppはSVMベースの画像分析によってメラノーマリスクを評価できる初のiPhone(アイフォーン)アプリです。健康志向の消費者は、時間や場所を問わず、iPhone、iPod touch(アイポッド・タッチ)、iPad(アイパッド)のほか、Android対応スマートフォンを利用して、メラノーマについて学習し、専門医に診てもらう必要があると思われる皮膚部位を特定することが容易になります。 昨年夏にiPhone向けに初めてリリースされたMelAppは、非常に高度な数学的アルゴリズムの特許保護技術と、画像に基づくパターン認識技術を利用して、アップロードされた画像を分析します。このアプリはジョンズ・ホプキンス大学メディカルセンターよりライセンスを受けた画像データベースを利用して、バリデーション(検証)が実施されまし
SWIFT(血栓除去を目的としたSolitaireの使用)試験の結果を国際脳卒中会議で2月3日に発表
2/3/2012 8:25:00 AM
--(BUSINESS WIRE)--(ビジネスワイヤ) -- コヴィディエン: 発表者: ジェフリー・セイバー(MD) SWIFT筆頭著者 カリフォルニア大学ロサンゼルス校 デイヴィッド・ゲフィン医科大学院UCLA脳卒中センター 神経学教授・センター神経学ディレクター 発表内容: SWIFT(Solitaire with the Intention for Thrombectomy、血栓除去を目的としたSolitaireの使用)試験の結果を、中部標準時午前8時にプレスカンファレンスにて発表します。続いて中部標準時正午に「最近の画期的臨床試験」のプレゼンテーションがあります。血行再建デバイスSolitaire™ FRはステントをベースとするコヴィディエンの機械的血栓除去用デバイスで、血行再建と血栓回収の機能を単一の装置に組み込んでいます。デバイスは閉塞部を通過して留置するよう設計されているため、急性虚血性脳卒中の患者で血流を回復し、クロットを回収できる可能性を持っています。SWIFT試験の目的は、MERCI® Retrievalシステムとの比較で、血行再建デバイ
Company Profile for JPT Peptide Technologies GmbH
2/3/2012 8:10:00 AM
--(BUSINESS WIRE)--JPT Peptide Technologies is a DIN ISO 9001:2008 certified provider of innovative peptide products and services and a partner for research projects
Interested in displaying your company's press releases? Contact us now!
* Denotes required field
Title:
*
First Name:
*
Last Name:
*
Job Title:
*
Company/ organization:
*
Country
:
>
*
Where did you hear about us?::
*
Telehone (incl. area and/or country code):
*
Email:
Please indicate your specific interest in posting your company's news here:
Enter code below:
ABOUT US
CONTACT US
BECOME A MEMBER
ADVERTISE
EDITORIAL
PRIVACY
Copyright 2009 - 2011 Innovative Publishing Co. LLC, All Rights Reserved
Loading...